Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY14.31 CNY
Change Today +0.69 / 5.07%
Volume 47.4M
600351 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for yabao pharmaceutical group-a (600351)

Year over year, Yabao Pharmaceutical Group Co., Ltd has been able to grow revenues from CNY1.6B CNY to CNY1.9B CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 55.99% to 47.46%. This was a driver that led to a bottom line growth from CNY118.2M CNY to CNY170.1M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues1,657.11,263.21,604.41,889.7
Other Revenues5.63.320.5--
TOTAL REVENUES1,662.71,266.61,624.91,889.7
Cost of Goods Sold935.2628.0898.3896.7
GROSS PROFIT727.5638.6726.6992.9
Selling General & Admin Expenses, Total387.1476.8577.2746.4
Other Operating Expenses67.023.520.716.7
OTHER OPERATING EXPENSES, TOTAL454.1500.2597.9763.1
OPERATING INCOME273.4138.4128.7229.8
Interest Expense-45.9-52.2-48.3--
Interest and Investment Income4.25.310.92.2
NET INTEREST EXPENSE-41.6-46.9-37.42.2
Currency Exchange Gains (Loss)-0.20.00.1--
Other Non-Operating Income (Expenses)-2.5-0.3-0.4-40.8
EBT, EXCLUDING UNUSUAL ITEMS229.191.191.0191.2
Gain (Loss) on Sale of Investments--0.0-0.30.4
Gain (Loss) on Sale of Assets-10.42.123.4--
Other Unusual Items, Total22.735.816.1-1.5
Other Unusual Items22.735.816.1--
EBT, INCLUDING UNUSUAL ITEMS241.4129.0130.1190.1
Income Tax Expense44.019.216.925.0
Minority Interest in Earnings-11.02.44.95.0
Earnings from Continuing Operations197.4109.9113.3165.1
NET INCOME186.4112.3118.2170.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS186.4112.3118.2170.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS186.4112.3118.2170.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600351:CH CNY14.31 CNY +0.69

600351 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600351.
View Industry Companies
 

Industry Analysis

600351

Industry Average

Valuation 600351 Industry Range
Price/Earnings 57.3x
Price/Sales 4.8x
Price/Book 5.0x
Price/Cash Flow 58.3x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YABAO PHARMACEUTICAL GROUP-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.